Art

J-GLOBAL ID：201802220200113341   Reference number：18A0417891

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

より深い分子応答は慢性期慢性骨髄白血病を持つ患者におけるイマチニブ中断後の無治療寛解維持に関する予測因子である:JALSG-STIM213研究

Author (32)： TAKAHASHI Naoto (Akita Univ. Graduate School of Medicine, Akita, JPN) ,  TAUCHI Tetsuzo (Tokyo Medical Univ., Tokyo, JPN) ,  KITAMURA Kunio (Ichinomiya Municipal Hospital, Ichinomiya, JPN) ,  MIYAMURA Koichi (Japanese Red Cross Nagoya First Hospital, Nagoya, JPN) ,  SABURI Yoshio (Oita Prefectural Hospital, Oita, JPN) ,  HATTA Yoshihiro (Nihon Univ. School of Medicine, Tokyo, JPN) ,  MIYATA Yasuhiko (Nagoya Medical Center, Nagoya, JPN) ,  KOBAYASHI Shinichi (National Defense Medical Coll., Tokorozawa, JPN) ,  USUKI Kensuke (NTT Medical Center Tokyo, Tokyo, JPN) ,  MATSUMURA Itaru (Kindai Univ., Osaka-Sayama, JPN) ,  MINAMI Yosuke (National Cancer Center Hospital East, Kashiwa, JPN) ,  USUI Noriko (Jikei Univ. School of Medicine, Tokyo, JPN) ,  FUKUDA Tetsuya (Tokyo Medical and Dental Univ., Tokyo, JPN) ,  TAKADA Satoru (Saiseikai Maebashi Hospital, Maebashi, JPN) ,  ISHIKAWA Maho (Saitama Medical Univ. International Medical Center, Saitama, JPN) ,  FUJIMAKI Katsumichi (Fujisawa City Hospital, Fujisawa, JPN) ,  GOMYO Hiroshi (Hyogo Cancer Center, Akashi, JPN) ,  SASAKI Osamu (Miyagi Cancer Center, Natori, JPN) ,  OHISHI Kohshi (Mie Univ. Hospital, Tsu, JPN) ,  MIYAKE Takaaki (Shimane Univ. Hospital, Izumo, JPN) ,  IMAI Kiyotoshi (Sapporo Hokuyu Hospital, Sapporo, JPN) ,  SUZUSHIMA Hitoshi (Kumamoto Shinto General Hospital, Kumamoto, JPN) ,  MITSUI Hideki (Otemae Hospital, Osaka, JPN) ,  TOGITANI Kazuto (Kochi Medical School, Kochi, JPN) ,  KIGUCHI Toru (Chugoku Central Hospital, Fukuyama, JPN) ,  ATSUTA Yoshiko (Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, JPN) ,  OHTAKE Shigeki (Kanazawa Univ., Kanazawa, JPN) ,  OHNISHI Kazunori (Japanese Red Cross Aichi Blood Center, Seto, JPN) ,  KOBAYASHI Yukio (International Univ. Health and Welfare, Tokyo, JPN) ,  KIYOI Hitoshi (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  MIYAZAKI Yasushi (Nagasaki Univ., Nagasaki, JPN) ,  NAOE Tomoki (Nagoya Medical Center, Nagoya, JPN)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 107  Issue： 2  Page： 185-193  Publication year： Feb. 2018 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *chronic myeloid leukemia ,...
Semi thesaurus term： *BCR-ABL1 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0417891&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (3)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Treatment for tumors in general  (GE03031L)

Substance index (1)： Imatinib

Reference (39)：

• Garcia-Manero G, Faderl S, O’Brien S, Cortes J, Talpaz M, Kantarjian HM. Chronic myelogenous leukemia: a review and update of therapeutic strategies. Cancer. 2003;98(3):437-57.
• Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54(1):8-29.
• Redaelli A, Bell C, Casagrande J, Stephens J, Botteman M, Laskin B, et al. Clinical and epidemiologic burden of chronic myelogenous leukemia. Expert Rev Anticancer Ther. 2004;4(1):85-96.
• Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med. 1996;100(5):555-70.
• Faderl S, Talpaz M, Estrov Z, Kantarjian HM. Chronic myelogenous leukemia: biology and therapy. Ann Intern Med. 1999;131(3):207-19.

Terms in the title (14)： 分子 ,  応答 ,  慢性期 ,  慢性 ,  骨髄 ,  白血病 ,  患者 ,  イマチニブ ,  中断 ,  治療 ,  寛解維持 ,  予測因子 ,  JALSG ,  研究